BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3094656)

  • 21. HIV antibodies in a remote rural area in Rwanda, Central Africa: an analysis of potential risk factors for HIV seropositivity.
    Van de Perre P; Le Polain B; Carael M; Nzaramba D; Zissis G; Butzler JP
    AIDS; 1987 Dec; 1(4):213-5. PubMed ID: 3126767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection through normal heterosexual contact in Uganda.
    Sewankambo NK; Carswell JW; Mugerwa RD; Lloyd G; Kataaha P; Downing RG; Lucas S
    AIDS; 1987 Jul; 1(2):113-6. PubMed ID: 3130076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
    Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
    JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroepidemiology of human immunodeficiency virus in Africa from 1970 to 1974.
    Sher R; Antunes S; Reid B; Falcke H
    N Engl J Med; 1987 Aug; 317(7):450-1. PubMed ID: 3475575
    [No Abstract]   [Full Text] [Related]  

  • 25. Seroepidemiological investigations on human immunodeficiency virus infections in some parts of India.
    Bose M; Pavri KM; Israel Z; Dhorje SP; Divekar A; Ramamoorthy CL; Rodrigues JJ; Athalye NK
    Indian J Med Res; 1988 Mar; 87():209-12. PubMed ID: 3165084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
    Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
    Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of antibodies to HIV-2/HTLV-4 in six central African nations.
    Kanki PJ; Allan J; Barin F; Redfield R; Clumeck N; Quinn T; Mowovondi F; Thiry L; Burny A; Zagury D
    AIDS Res Hum Retroviruses; 1987; 3(3):317-22. PubMed ID: 2893632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strain-specific antibody response to Lassa virus in the local population of west Africa.
    Emmerich P; Günther S; Schmitz H
    J Clin Virol; 2008 May; 42(1):40-4. PubMed ID: 18164653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of antibodies to the human immunodeficiency virus in sera from Africa prior to 1975.
    Levy JA; Pan LZ; Beth-Giraldo E; Kaminsky LS; Henle G; Henle W; Giraldo G
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7935-7. PubMed ID: 3464008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole blood collection on filter paper is an effective means of obtaining samples for human immunodeficiency virus antibody assay.
    Varnier OE; Lillo FB; Reina S; De Maria A; Terragna A; Schito G
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):131-6. PubMed ID: 3284554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serology in HIV infection: comparison of indirect immunofluorescence, Western blot and enzyme immunoassay].
    Schmidt BL; Hutterer J; Kunz C; Gschnait F
    Wien Med Wochenschr; 1988 Apr; 138(8):174-80. PubMed ID: 3043921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening haemodialysis patients for infection with human immune deficiency virus (HIV).
    De Santo NG; Tarro G; Giordano C; Capodicasa G; Esposito C; Flaminio G; Sodano G; Caropreso MR; Pluvio M; Giordano D
    J Infect; 1987 May; 14(3):229-32. PubMed ID: 3035028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of antibodies to human immunodeficiency virus (HIV) in eluates from whole blood impregnated filter paper discs.
    Lindhardt BO; Bygbjerg IC; Ulrich K; Petersen HD; Lausen I; Frederiksen B
    J Virol Methods; 1987 Oct; 18(1):73-7. PubMed ID: 3480292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-2: slower, still deadly.
    Brown P
    WorldAIDS; 1992 Jul; (22):10. PubMed ID: 12318129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Religious and cultural traits in HIV/AIDS epidemics in sub-Saharan Africa.
    Velayati AA; Bakayev V; Bahadori M; Tabatabaei SJ; Alaei A; Farahbood A; Masjedi MR
    Arch Iran Med; 2007 Oct; 10(4):486-97. PubMed ID: 17903054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme immunoassays for the demonstration of antibodies to HIV-2SBL-6669 and HTLV-IV (SIVmac).
    Biberfeld G; Thorstensson R; Bergström M; Naucler A; Costa CM
    AIDS; 1988 Jun; 2(3):195-9. PubMed ID: 3134913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of country-level activities in population education in the African region: Unesco experience.
    UNESCO. Regional Office for Education in Africa
    Educafrica; 1985 Jun; (12):199-207. PubMed ID: 12268119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of serum neutralization response to the human immunodeficiency virus (HIV).
    Groopman JE; Benz PM; Ferriani R; Mayer K; Allan JD; Weymouth LA
    AIDS Res Hum Retroviruses; 1987; 3(1):71-85. PubMed ID: 2441727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance for AIDS in a central African city. Kinshasa, Zaire.
    Mann JM; Francis H; Quinn T; Asila PK; Bosenge N; Nzilambi N; Bila K; Tamfum M; Ruti K; Piot P
    JAMA; 1986 Jun; 255(23):3255-9. PubMed ID: 3012131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.